Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality‐dependent prognostic patterns-Reference-Cited by-同舟云学术

Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality‐dependent prognostic patterns

Published:2022-07-06 Issue:6 Volume:48 Page:
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathology Appl Neurobio

Author:

Luo Shangyi¹²,Zhang Yajing¹²,Jia Ying²³,Zhang Xue¹²

Affiliation:

1. NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics Harbin Medical University Harbin China

2. Heilongjiang Province Key Laboratory of Child Development and Genetic Research Harbin Medical University Harbin China

3. Department of Child and Adolescent Health, Public Health College Harbin Medical University Harbin China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

Wiley

Subject

Physiology (medical),Neurology (clinical),Neurology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nan.12831

Reference48 articles.

1. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

2. The Somatic Genomic Landscape of Glioblastoma

3. Clonal evolution in cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal instability: a key driver in glioma pathogenesis and progression;European Journal of Medical Research;2024-09-04

2. Epithelial–Mesenchymal Transition Related Score Functions as a Predictive Tool for Immunotherapy and Candidate Drugs in Glioma;Journal of Chemical Information and Modeling;2024-08-08

3. A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma;JHEP Reports;2023-06

4. WITHDRAWN: A transcriptomic intratumor heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma;JHEP Reports;2023-03